Supplementary Figure 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Authors:
- Myrto MoutafiMyrto Moutafi
- Georgia-Angeliki KoliouGKGeorgia-Angeliki Koliou
- George PapaxoinisGPGeorge Papaxoinis
- Panagiota EconomopoulouPEPanagiota Economopoulou
- Ioannis KotsantisIKIoannis Kotsantis
- Maria GkotzamanidouMGMaria Gkotzamanidou
- Maria AnastasiouMAMaria Anastasiou
- Dimitrios PectasidesDPDimitrios Pectasides
- Efthymios KyrodimosEKEfthymios Kyrodimos
- Alexander DelidesADAlexander Delides
- Evangelos GiotakisEGEvangelos Giotakis
- Nikolaos G. PapadimitriouNPNikolaos G. Papadimitriou
Open Access
- 10 August 2023
- other
- Published by American Association for Cancer Research (AACR)